AstraZeneca X Mindpeak: Transforming Early Breast Cancer Detection with AI

March 19, 2025

We’re beyond excited to partner with AstraZeneca to evaluate and deploy our AI-powered solution for early breast cancer detection in multiple centers around the globe.

The collaboration investigates the role of AI in enhancing diagnostic accuracy, optimizing pathology workflows, and supporting pathologists in detecting invasive breast cancer and Ductal Carcinoma in Situ (DCIS) more resource-efficiently and at an earlier stage.

Breast cancer is the most common cancer among women worldwide, with over 2.3 million new cases annually. Early and accurate diagnosis is critical, yet many healthcare systems struggle with pathologist shortages and increasing case volumes — to delays in detection and treatment.

By integrating our AI products into digital pathology workflows, we strive to accelerate diagnoses, boost efficiency, and ultimately improve patient outcomes.This is a major milestone in the future of AI-driven digital pathology — and we’re just getting started!

‍

Read the full article here: https://lnkd.in/eNSA2ZHg

Press Release

Related reading

Press Release

8 min read

New partnership announcement

Mindpeak GmbH and Lumea announce a strategic partnership to advance AI in pathology!

This partnership brings Mindpeak’s AI applications to Lumea’s BxLink platform, offering users broader access to state-of-the-art tools for improved diagnostic precision and enhanced lab efficiency.

Read more about this exciting partnership: https://lnkd.in/gnWv9pyf

Press Release

8 min read

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology

The future of pathology is here!

‍ZEISS Microscopy and Mindpeak GmbH partner to develop an integrated Multiplex Immunofluorescence (mIF) solution, combining ZEISS’s advanced instruments with Mindpeak’s AI-powered pathology analysis.

Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF. The joint solution will integrate both companies' existing offerings to enhance the value for the users and address multiple market segments.The partnership combines complementary competencies and expands both companies’ reach in the growing mIF market.

…making excellence a habit! Mindpeak achieves ISO13485:2016 certification for its QMS

Today, we’re excited to share a major milestone: Mindpeak GmbH has officially achieved ISO 13485:2016 certification from the British Standards Institution (BSI)!

This globally recognized certification confirms that our Quality Management System meets the highest international standards for safety, reliability, and compliance in the medical device industry. It reflects our dedication to delivering innovative solutions that healthcare providers can trust.

At Mindpeak, quality is at the heart of everything we do. From product design to delivery, this certification underscores our commitment to ensuring that our products meet the most rigorous regulatory requirements while improving outcomes for patients and healthcare professionals alike.

This accomplishment wouldn’t have been possible without the dedication and expertise of our team. Here’s to continuing to raise the bar in quality, safety, and innovation!

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting

Request consult